AbCellera IPO Presentation Deck

PARTNERSHIP BUSINESS MODEL HELP EVERYONE & SHARE IN THE SUCCESS. target PARTNER BIOTECH, PHARMA ABCELLERA mAb Pre-clinical DISCOVERY RESEARCH FEES Near-term revenue from research payments (capital efficient) Phase 1 Phase 2 Phase 3 Approval MILESTONES Multimillion dollar potential clinical and commercial milestone payments Building a diversified portfolio of milestones & royalties (primary value driver) AbCellera Commercial Sale ROYALTIES Majority of risk-adjusted value from royalty on commercial therapeutic sales

View entire presentation